Re: TD Zenith Capital Corp | Grey Market : ZHCLF
in response to
by
posted on
Oct 16, 2020 01:28PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
It has a .0529 value today with a 5.5k volume; up .047 or a 333.61% increase,
carman